Cell fusion may restart inflammation by combining tissue and immune programs in persistent hybrids
Hybrids formed by fusion of myeloid descendants of blood-forming precursors with damaged-tissue cells may restart inflammation. Persistent relapse in cultures where fusion is reliably excluded, abolished by correcting contact geometry, RNA editing or matrix peptides, would reject this as the main explanation.
Stage of verification
- Hypothesis published2026-09-30
- Not enough research data
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Harmful clone
Myeloid–tissue hybrid cells
Cells formed by fusion of myeloid cells with tissue cells, containing genomes from both lineages
Where this hypothesis actsIn damaged tissues after the environment has normalized and useful regeneration is complete
Hypotheses on this target 1
Clearance restoration
Elimination1
Immunosuppression
Population balance

What is proposed
Elimination
Selectively eliminate confirmed hybrid cells
With whatNot stated in the record
HowSelect hybrids with confirmed genomes from both lineages for removal after useful regeneration; the removal technique is not stated
Possible result
Possible stabilization of SPV_6 and reduced inflammatory recurrence and repeated damage across organs
From the recordИзбирательное устранение таких гибридов после завершения полезной регенерации должно стабилизировать SPV_6 и уменьшить повторное повреждение нескольких органов.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Inflammation may return even after the conditions around damaged tissue have recovered. The unexpected proposal is that an immune cell and a tissue cell could fuse, leaving one lasting cell that carries both sets of genetic material and restarts the response. This is a hypothesis generated by the pipeline, not a measured result.
- An immune descendant of a blood-forming precursor fuses with a cell in damaged tissue.
- The resulting hybrid retains genetic material from both cell groups.
- Previously separate tissue and immune gene-control activities now operate within one persistent cell.
- The surroundings return to recovered conditions, but the hybrid retains the proposed inflammation-restarting activity.
- The hybrid releases inflammation-promoting substances and renews tissue injury.
- Selective removal of confirmed hybrids after useful repair is predicted to prevent inflammation from returning after another mild challenge.
Two separate alarm systems are rewired into one box that keeps sounding after the original fault has been repaired. Silencing both circuits could look like stopping two alarms that trigger each other, even though the trouble now sits inside one box.
Where the picture breaks: Cells do not have fixed wiring, and combining genetic material does not by itself establish a persistent inflammatory state. The picture explains the proposed location of the problem, not evidence that it exists.
- Master questionstep 01 of 04
A shared cause of several aging processes could offer a way to improve several body systems through one targeted intervention.
Rests on: The goal explicitly proposes that aging processes can reinforce one another and asks for ideas that target a common causal link.
Stated in the chain - Goal pillarstep 02 of 04
Recovery should remain stable instead of giving way to a lasting damaged state.
Rests on: The search for a shared cause is narrowed to whatever prevents recovery from lasting.
AssumptionThe chain takes durable recovery as a candidate shared target without establishing that failure to maintain it drives aging across several systems.
- Gap questionstep 03 of 04
Returning inflammation might originate in lasting changes within tissue cells, within blood-forming precursor cells that produce immune descendants, or in reinforcement between these groups. Temporarily suppressing their activity separately and together is proposed as a way to distinguish those possibilities.
Rests on: The preceding stage identifies persistence of a damaged state as the problem to explain.
AssumptionThe narrowing assumes that returning inflammation is a relevant form of failed recovery and that these two cell groups carry the lasting changes. The preceding stage does not establish either point.
- Hypothesisstep 04 of 04
Persistent hybrid cells, meaning cells formed by fusion of an immune cell with a damaged-tissue cell, are proposed to carry both groups' genomes, their sets of genetic material. Their combined gene-control activities could restart inflammatory secretion, the release of substances that promote inflammation, after surrounding cells recover. Removing these hybrids after useful repair is predicted to prevent recurrence and reduce repeated injury in several organs.
Rests on: The preceding question supplies the two candidate cell groups and the comparison between separate and combined suppression. The hypothesis places their activities inside one fused cell instead of requiring interaction between separate cells.
AssumptionThe proposed carrier is a persistent fused cell whose combined genetic material sustains inflammation-promoting activity. That carrier is an explicit mechanistic assumption; neither the preceding question nor the supplied sources establishes it. Its status as a proposal is not itself a missing argument.
What is carried, and what is not. Two supplied examples illustrate the evidence boundary: S3, a 2020 Nature Cell Biology study, reports fusion involving precursors of osteoclasts, the cells that break down bone, during mouse bone maintenance and repair, but not the proposed immune–tissue hybrids; S7, a 2011 American Journal of Pathology study, reports a lack of shared nuclear location of human and mouse genetic material suggesting absence of fusion in an injured newborn-mouse lung model receiving human blood-forming precursor cells, which does not exclude fusion elsewhere. The screened material therefore bears on fusion in related settings, but establishes neither the specific initiating fusion nor any complete causal link in the proposed six-link sequence, and does not establish the sequence end to end.S3S7
Where the reasoning is carried by something unstated · 3
- Goal pillar. The chain takes durable recovery as a candidate shared target without establishing that failure to maintain it drives aging across several systems.
- Gap question. The narrowing assumes that returning inflammation is a relevant form of failed recovery and that these two cell groups carry the lasting changes. The preceding stage does not establish either point.
- Hypothesis. The proposed carrier is a persistent fused cell whose combined genetic material sustains inflammation-promoting activity. That carrier is an explicit mechanistic assumption; neither the preceding question nor the supplied sources establishes it. Its status as a proposal is not itself a missing argument.
How a result here could mislead · 3
- A cell carrying both fluorescent labels could be mistaken for a hybrid even if the observation comes from two cells measured together, an engulfed cell, or label transfer in small membrane-bound packages. What closes it: The specified live recording of fusion and subsequent reading of genetic material from individual cells must establish both cellular origins in a genuine single hybrid. The design explicitly requires excluding those alternative sources of double labeling.
- A stronger effect of suppressing both cell groups' activities could be credited to mutual reinforcement between separate populations when both activities operate inside the same hybrid. What closes it: The source of returning inflammatory secretion must be assigned to genetically confirmed hybrids or separate cells after suppression is withdrawn. The design predicts that distinction, but does not specify how secretion will be assigned to individual cells.
- Continued inflammation after attempted hybrid removal could be read as refuting the hypothesis even if removal was incomplete; conversely, reduced inflammation could reflect unintended removal of other cells. What closes it: Hybrid depletion and the identities of other removed cells must be verified. The specified control removing the same number of neighboring nonhybrid cells is needed to separate hybrid identity from the effect of losing cells generally.
What would make this wrong. Persistent recurrence in cultures where fusion has been reliably excluded, together with elimination of that recurrence by correcting one of the supplied rival mechanisms, would refute hybrids as the main explanation. Those rivals locate the persistent cause in altered spacing at cell contacts that impairs debris removal, faulty handling of the cell's own genetic messages, or inflammation-promoting fragments of the material surrounding cells.
What it would change. If the predictions held, one candidate shared cause of recurrent injury would be a persistent fused-cell population, and recovery research would have to distinguish cooperation between separate cells from combined activity inside a single cell. Selective removal after useful repair would become a supported intervention to investigate in that tested system. A culture result would still not establish benefits in old animals, prevention of injury across organs, or longer life; the proposed stability outcome called SPV_6 is not defined in the supplied material.
Sources read · 8
Restorative macrophage-derived RNAseT2 stimulates muscle stem cell fusion via an SLK/N-WASP/actin bundling dependent axis. · Nature communications · 2026
“The present study did not explore how RNAseT2 may affect the programming of immune cells, but has explored the impact of secreted RNAseT2 on MuSC fusion.”
Does not settle: It does not establish fusion between myeloid descendants and damaged-tissue cells, persistent hybrid genomes, recurrent inflammatory secretion after environmental normalization, effects across organs, SPV_6, or selective elimination of hybrids.
Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1. · Scientific reports · 2020
“Osteoclasts are large, multinucleated cells that resorb bone. They arise from the fusion of myeloid progenitor cells, a process which is facilitated by two cytokines, M-CSF and RANKL.”
Does not settle: The source does not establish fusion between myeloid descendants and damaged-tissue cells, persistent hybrid genomes, renewed inflammatory secretion after environmental normalization, recurrence across organs, SPV_6 effects, or selective elimination of such hybrids.
Erythromyeloid progenitors give rise to a population of osteoclasts that contribute to bone homeostasis and repair. · Nature cell biology · 2020
“progenies of Cx3cr1 + yolk-sac macrophages provide long-lasting osteoclast precursors that participate in cell-cell fusion with local precursors and contribute to the postnatal bone remodeling in both physiological and pathological setting.”
Does not settle: Источник описывает слияние предшественников остеокластов при ремоделировании кости у мышей. Он не устанавливает слияние миелоидных клеток с клетками повреждённой ткани, сохранение патологического гибридного генома, возобновление воспалительной секреции после нормализации среды, повторное повреждение органов или эффект избирательного устранения гибридов.
Interaction of hematopoietic CD34+ CD45+ stem cells and cancer cells stimulated by TGF‑β1 in a model of glioblastoma in vitro. · Oncology reports · 2018
“U87 glioblastoma cells have a complex system of communication, including adhesive intercellular contacts, areas of interdigitation with dissolution of the cytoplasm, cell fusion, communication microtubes and microvesicles.”
Does not settle: Источник не устанавливает образование устойчивых гибридов миелоидных потомков с клетками повреждённой ткани, сохранение объединённого генома, повторный запуск воспалительной секреции после восстановления среды, влияние на SPV_6 или эффект избирательного устранения таких клеток.
Cell-surface phosphatidylserine regulates osteoclast precursor fusion. · The Journal of biological chemistry · 2018
“Bone-resorbing multinucleated osteoclasts that play a central role in the maintenance and repair of our bones are formed from bone marrow myeloid progenitor cells by a complex differentiation process that culminates in fusion of mononuclear osteoclast precursors.”
Does not settle: It does not establish fusion of myeloid progeny with damaged-tissue cells, persistent hybrid genomes, inflammatory reactivation after environmental normalization, effects across organs, SPV_6, or selective elimination of such hybrids.
Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells. · The American journal of pathology · 2011
“Lack of nuclear colocalization of human and murine genomic material suggested the absence of fusion.”
Does not settle: Источник описывает модель повреждения лёгких новорождённых мышей после введения человеческих CD34+ клеток. Он не устанавливает наличие или устойчивость гибридных клеток в других повреждённых тканях, их воспалительную секрецию после нормализации среды, влияние на SPV_6 или последствия их избирательного устранения.
Mitochondrion-targeted therapies for diabetic wound healing: from mechanism to therapeutic opportunity. · Burns & trauma · 2026
“Mitochrial transfer can occur through several mechanisms, including tunneling nanotubes (TNTs), extracellular vesicles (EVs), gap junctions (GJs), and cell fusion [ ].”
Does not settle: The source does not establish persistent tissue–myeloid hybrid cells, genomic fusion, recurrent inflammatory secretion after environmental normalization, selective hybrid-cell elimination, or effects on SPV_6 and multi-organ reinjury.
[Cognitive Impairment as a Sequela of COVID-19: Pathophysiology and Prospects for Treatment]. · Rinsho shinkeigaku = Clinical neurology · 2023
“Persistent infection could lead to cognitive impairments through mechanisms such as neurotoxicity mediated by spike proteins, neuroinflammation induced by cytokines, and neuronal cell fusion (syncytia).”
Does not settle: Абстракт не устанавливает существование устойчивых гибридов миелоидных потомков с клетками повреждённой ткани, сохранение объединённого генома, повторный запуск воспалительной секреции после нормализации среды, действие совместного подавления программ, устранение гибридов, влияние на SPV_6 или повторное повреждение органов.
The gap this hypothesis explains
Something is claimed here, but it rests on evidence too thin to carry weight.
Does temporarily silencing memory in tissue cells, blood-forming cells, or both stop inflammation returning after conditions improve?
Original wording · exactly as the pipeline generated it
Что возвращает воспаление после нормализации среды: автономная память тканевых клеток, память кроветворных предшественников или их взаимное подкрепление, выявляемое раздельным и совместным обратимым подавлением этих программ?
What this question is asking
The question asks where lasting changes that might restart inflammation are stored. It compares memory within tissue cells, memory in the blood-forming precursor cells that produce immune cells, and a cycle in which these two sources keep reactivating each other. The proposed comparison is between temporarily suppressing each memory program separately and suppressing both together after the original harmful conditions have been corrected. The question assumes that memory of physical conditions in tissue cells and inherited memory of altered cellular chemistry have already been demonstrated separately, but that their interaction in an aged organism remains unresolved. Its intended measure of success is recovery toward a common stable condition over weeks, followed by limited remaining loss of function during repeated challenges over months; the supplied material does not specify the challenges or acceptable limits.
- Inflammation
- A response involving immune cells and tissue signals to injury or harmful exposure. Here, the outcome is whether that response returns after the original harmful conditions are corrected.
- Cellular or inflammatory memory
- A lasting change caused by an earlier exposure that alters a cell's later behavior or the behavior of its descendants. It names a class of effects, not conscious memory or one universally defined program.
- Tissue cells and autonomous tissue-cell memory
- Tissue cells are cells within organs; the question contrasts them with blood-forming precursors. Autonomous memory would mean that a retained change within those tissue cells contributes to later behavior without continued exposure to the original trigger; it does not necessarily mean independence from every outside signal.
- Blood-forming stem and precursor cells
- Cells that give rise to blood cells, including immune cells. Stem cells can maintain their own population, while precursors are further along the path toward particular blood-cell types; memory in this compartment could affect subsequently produced cells.
- Immune cells
- Cells involved in defense and responses to damage. The question concerns whether their behavior reflects lasting changes in the cells that produced them.
- Mechanical memory
- A lasting cellular effect of earlier physical conditions, such as forces or the properties of surrounding material. The pipeline labels this component RL-1, but supplies no definition of that label or direct finding establishing the particular program.
- Metabolism and inherited metabolic memory
- Metabolism is the set of chemical processes through which cells obtain and use energy and materials. Inherited metabolic memory here means that effects of an earlier metabolic state persist in descendant cells, rather than inheritance between parents and offspring; the pipeline labels it RL-2 without defining that label.
- Memory program and reversible suppression
- A memory program is shorthand for cellular processes that maintain an exposure's lasting effects. Reversible suppression means temporarily reducing those processes and then allowing the suppressing effect to end; temporary improvement alone would not establish permanent removal of memory.
- Mutual reinforcement
- A cycle in which changes in one cell group help maintain or restore changes in another, which then acts back on the first. It is one of the possibilities being asked about, not a demonstrated relationship in the supplied evidence.
- Environmental correction
- Removal or correction of the harmful conditions thought to sustain inflammation. The input does not specify those conditions or a measurement confirming that they have been corrected.
- Functional deficit
- A remaining reduction in how well a tissue or organism works. The pipeline asks for this loss to remain limited, but supplies neither the function being measured nor its acceptable limit.
- Epithelial cells
- Cells that cover body surfaces and line internal spaces and organs. S3 identifies them as cells capable of acquiring memory.
- Cell-surface signaling protein
- A protein at a cell's surface that helps transmit signals into the cell when an activating partner binds. In S2, memory preserves such a protein, supporting continued responsiveness to activating signals.
- Neutrophils
- A type of immune cell produced from blood-forming cells. S8 measures their increased arrival in the abdominal cavity during a subsequent infection.
- Candida albicans
- The fungal species used for the earlier exposure and subsequent infection in S8. That result concerns a response to infection, rather than demonstrated spontaneous return of inflammation after environmental correction.
Mechanical memory in tissue cells and inherited metabolic memory in blood-forming precursors have been demonstrated separately, and their interaction in an aged organism has not been established.
Tissue cells are cells within an organ, while blood-forming precursors generate blood cells, including immune cells. The assumption is that the first group can retain effects of earlier physical conditions and the second can pass effects of altered cellular chemistry to its descendants. If established in the relevant setting, these would provide two distinct sources whose contributions to returning inflammation could be compared.
The sources support a narrower premise: lasting changes occur in some tissue-cell settings, and prior exposure of blood-forming cells can affect the responses of their descendants. S2 reports inflammatory memory in pancreatic cancer cells, and S3 reports that cells covering or lining body surfaces acquire memories in living organisms. S8 reports a changed response in immune cells descended from previously exposed blood-forming cells in mice. These findings do not establish the specific mechanical and inherited metabolic programs named in the pipeline statement, their persistence after environmental correction in aged organisms, or their mutual reinforcement. None of the supplied excerpts establishes their interaction; that limitation does not establish that the wider literature lacks such work.S2S3S8
The same question asked without the part nothing read establishes:
- After harmful conditions are corrected, does temporarily suppressing lasting changes in tissue cells, blood-forming precursors, or both prevent inflammation from returning?
- What evidence distinguishes tissue-cell memory from blood-forming-precursor memory as a source of returning inflammation after harmful conditions are corrected?
- Tissue-cell memory sustains recurrence Under this outcome, tissue cells would retain the change that restarts inflammation after their surroundings improve. Suppressing that memory would prevent recurrence under the conditions examined, while suppressing memory only in blood-forming precursors would leave the tissue source active.
- Blood-forming-precursor memory sustains recurrence Under this outcome, blood-forming precursors would continue producing immune cells with an altered response. Suppressing that precursor memory would prevent recurrence under the conditions examined, while suppressing tissue-cell memory alone would leave the continuing supply of altered immune cells.
- Both memories reinforce each other Under this outcome, activity arising from either cell group would help restore the altered state in the other. Separate temporary suppression would therefore permit recurrence, whereas joint suppression could interrupt the cycle; persistence of that interruption after suppression ends would determine whether recovery lasts.
- Neither proposed memory explains recurrence If recurrence continued despite effective joint suppression, these two memories would not sufficiently explain its return. The question's proposed choice between them would then leave the actual cause unresolved.
Correcting an ongoing source of inflammation and removing a lasting change caused by that source are different steps. If tissue cells retain a change that restarts inflammation, correcting their surroundings could leave that source of recurrence intact. If blood-forming precursors retain the relevant change, the immune cells they subsequently produce could instead carry the altered response forward. If the two sources reactivate each other, suppressing only one could allow the other to restore the cycle. These are conditional consequences of the question's proposed mechanism: confusing them could lead to mistaking temporary improvement for lasting recovery.
Механическая память RL-1 и наследуемая метаболическая память RL-2 показаны раздельно; их взаимодействие в старом организме не установлено.
После устранения стимула траектории сходятся за недели; остаточный функциональный дефицит остаётся ниже заданных границ при повторных нагрузках месяцами.
Неизвестно, какая память восстанавливает патологическое состояние после коррекции среды и достаточно ли устранения одного источника для устойчивого общего эффекта.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Возврат воспаления поддерживают устойчивые гибридные клетки, возникшие при слиянии миелоидных потомков кроветворных предшественников с клетками повреждённой ткани. Объединение геномов помещает тканевую и иммунную программы в одну клетку. После нормализации среды такой гибрид вновь запускает воспалительную секрецию, даже когда окружающие клетки восстановились. Совместное подавление двух программ поэтому может действовать внутри гибрида и ошибочно восприниматься как доказательство взаимного подкрепления двух независимых клеточных популяций. Предполагаемое общее причинное звено представляет собой сохранение гибридного генома с патологическим сочетанием регуляторных программ. Избирательное устранение таких гибридов после завершения полезной регенерации должно стабилизировать SPV_6 и уменьшить повторное повреждение нескольких органов.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
После раздельного и совместного обратимого подавления тканевой и кроветворной программ воспаление возвращается преимущественно из клеток, в которых подтверждены геномы обеих линий. Удаление только этих клеток устраняет рецидив после повторной малой нагрузки; удаление такого же числа соседних негибридных клеток этого эффекта не даёт. Обнаружение устойчивого рецидива в культурах с надёжно исключённым слиянием и его устранение коррекцией геометрии контакта, редактирования РНК или матриксных пептидов опровергает гипотезу как основное объяснение.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies an observable cellular source of recurrent inflammation, contrasting outcomes of selective cell removal, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Начальная проверка возможна в совместных культурах с различимыми генетическими метками двух линий, прижизненной регистрацией слияния и последующим секвенированием отдельных клеток. Совпадения двух флуоресцентных меток недостаточно: необходимо исключить клеточные дублеты, поглощённые клетки и перенос меток везикулами. Избирательное удаление подтверждённых гибридов осуществимее сначала в культуре; перенос на старых животных потребует отдельной валидации системы.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
После раздельного и совместного обратимого подавления тканевой и кроветворной программ воспаление возвращается преимущественно из клеток, в которых подтверждены геномы обеих линий. Удаление только этих клеток устраняет рецидив после повторной малой нагрузки; удаление такого же числа соседних негибридных клеток этого эффекта не даёт. Обнаружение устойчивого рецидива в культурах с надёжно исключённым слиянием и его устранение коррекцией геометрии контакта, редактирования РНК или матриксных пептидов опровергает гипотезу как основное объяснение.
- Rival 01 of 03What would separate them
Wider cell contacts may prevent enzyme exclusion, impair clearance and renew inflammation predicts: При одинаковых плотности лиганда, сродстве рецептора, составе клеток и текущей среде изменение только длины инертного молекулярного соединителя меняет присутствие CD45 в контакте, фосфорилирование рецептора и вероятность завершённого поглощения. Короткий контакт восстанавливает очистку и предотвращает последующее воспаление при сохранении прежних ядерных программ. Укорочение внеклеточной части CD45 должно отменять этот эффект, поскольку укороченная фосфатаза снова помещается в контакт. Отсутствие такой зависимости при подтверждённом изменении расстояния отвергает геометрическое объяснение.
- Rival 02 of 03What would separate them
Underedited ribonucleic acid may sustain inflammation through an interferon feedback loop predicts: В очищенных тканевых культурах после удаления иммунных клеток возвращению воспаления предшествуют рост конкретных недостаточно отредактированных двуцепочечных РНК и активация MDA5. Адресное разрушение этих транскриптов или восстановление каталитически активного ADAR1 предотвращает рецидив; каталитически неактивный вариант не предотвращает. Для доказательства хранения состояния краткое вмешательство должно давать эффект после своей отмены, а интерфероновая стимуляция должна воспроизводимо восстанавливать образование причинных транскриптов. Если редактирование нормализовано, но воспаление возвращается и устраняется только коррекцией контакта или матрикса, гипотеза отвергается.
- Rival 03 of 03Matrix breakdown may restart inflammation through a peptide-driven feedback loop
Not yet published.
What would separate themMatrix breakdown may restart inflammation through a peptide-driven feedback loop predicts: Бесклеточная пептидная фракция ранее повреждённой ткани запускает привлечение нейтрофилов в системе из клеток без прежней истории воздействия. Эффект исчезает после избирательного удаления PGP и возвращается при добавлении синтетического пептида в измеренной исходной концентрации. Замена клеток при сохранённом матриксе допускает рецидив; химическая обработка матрикса при сохранённых клетках предотвращает его. Сохранение эффекта после подтверждённого удаления причинных пептидов, особенно при зависимости от MDA5 или геометрии фагоцитарного контакта, опровергает гипотезу.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
В модели наследственного поражения печени восстановление после пересадки костного мозга сопровождалось образованием клеток с донорским и хозяйским геномами и изменением экспрессии донорского генома. Это подтверждает возможность объединения линий, но не воспалительную функцию гибридов. [Vassilopoulos et al., Nature, 2003](https://www.nature.com/articles/nature01539).
Биология воспалительной памяти и регенерации. Пересмотру подлежал бы учебный раздел «Клеточная автономность и наследование эпигенетических состояний»: часть долговременной памяти пришлось бы объяснять физическим объединением клеточных геномов.
Избирательное удаление редких генетически подтверждённых гибридов предотвращает возврат воспаления одновременно в нескольких органах, хотя эпигенетические признаки прежнего воздействия в обычных тканевых и кроветворных клетках сохраняются.
Слияние клеток при регенерации известно, существуют и обзоры многоядерных клеток при старении. Радикальна более узкая гипотеза: гибриды являются необходимым источником возврата воспаления и объясняют эффект совместного подавления тканевой и кроветворной программ. Целевой поиск не выявил работы, утверждающей именно это. Исчерпывающее доказательство отсутствия такой публикации отсутствует; соответствие критерию новизны предварительное.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.